Horizon Therapeutics Public Ltd Co
HZNPDelisted Oct 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492426
Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Horizon Therapeutics Public Ltd Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Horizon Therapeutics Public Ltd Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sherman Jeffrey W | EVP and Chief Medical Officer | 0Indirect | Oct 6, 2023 | 0 |
| Grey Michael G | Director | 0Indirect | Oct 6, 2023 | 0 |
| Santini Gino | Director | 0Indirect | Oct 6, 2023 | 0 |
| Watkins Thomas | Director | 0Indirect | Oct 6, 2023 | 0 |
| Himawan Jeff | Director | 0Indirect | Oct 6, 2023 | 0 |
| Walbert Timothy P | Chairman, President and CEO | 0Indirect | Oct 6, 2023 | 0 |
| Mahony Susan | Director | 0Indirect | Oct 6, 2023 | 0 |
| Shannon James Samuel | Director | 0Indirect | Oct 6, 2023 | 0 |
| DesJardin Michael A. | EVP, Technical Operations | 0 | Oct 6, 2023 | 0 |
| Daniel William F | Director | 0Indirect | Oct 6, 2023 | 0 |
| Witz Pascale | Director | 0Indirect | Oct 6, 2023 | 0 |
| Pasternak Andy | EVP, Chief Strategy Officer | 0 | Oct 6, 2023 | 0 |
| Thompson Elizabeth H.Z. | EVP, Research & Development | 0 | Oct 6, 2023 | 0 |
| Clayton Sean M. | EVP, General Counsel | 0Indirect | Oct 6, 2023 | 0 |
| Cox Aaron | EVP, Chief Financial Officer | 0 | Oct 6, 2023 | 0 |
| McIlvenny Patrick | Chief Accounting Officer | 0 | Oct 6, 2023 | 0 |
| Leonardi Jacopo | Pres., Global Commercial Ops | – | Jun 3, 2022 | 0 |
| Hoelscher Paul W. | EVP, CFO | 1,049 | Apr 22, 2022 | 0 |
| McHugh Miles W | Sr VP & Princ. Acctg Officer | 46,635 | Jan 6, 2022 | 0 |
| Moze Barry | EVP, Chief Admin. Officer | 138,174 | Jan 6, 2022 | 0 |
| Beeler Brian K | EVP, General Counsel | 62,775 | Sep 17, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2022 (view filing) | Aug 4 | 4 days | Clayton Sean M.EVP, General Counsel | PPurchase | +745 | $66.67 | +$49.7K | New position745 after | |
| Dec 13, 2022 (view filing) | Dec 12 | 1 day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −28.4K | $111.45 | −$3.16M | −25.1%84.4K after | 2 lots |
| Dec 14, 2022 (view filing) | Dec 13 | 1 day | Pasternak AndyEVP, Chief Strategy Officer | SSale | −30.2K | $112.61 | −$3.40M | −47.0%34.0K after | 2 lots |
| Jan 6, 2023 (view filing) | Jan 6 | Same day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −5.19K | $113.29 | −$587.6K | −9.5%49.3K after | |
| Jan 12, 2023 (view filing) | Jan 10-11 | 2 days | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −6.74K | $113.08 | −$761.7K | −15.7%36.2K after | 2 lots |
| Jan 17, 2023 (view filing) | Jan 13 | 4 days | Cox AaronEVP, Chief Financial Officer | SSale | −36.1K | $113.17 | −$4.09M | −99.2%277 after | |
| Jan 18, 2023 (view filing) | Jan 17 | 1 day | Pasternak AndyEVP, Chief Strategy Officer | SSale | −27.1K | $113.03 | −$3.07M | −32.5%56.3K after |